Literature DB >> 30278789

Electroencephalographic Biomarkers for Treatment Response Prediction in Major Depressive Illness: A Meta-Analysis.

Alik S Widge1, M Taha Bilge1, Rebecca Montana1, Weilynn Chang1, Carolyn I Rodriguez1, Thilo Deckersbach1, Linda L Carpenter1, Ned H Kalin1, Charles B Nemeroff1.   

Abstract

OBJECTIVE: Reducing unsuccessful treatment trials could improve depression treatment. Quantitative EEG (QEEG) may predict treatment response and is being commercially marketed for this purpose. The authors sought to quantify the reliability of QEEG for response prediction in depressive illness and to identify methodological limitations of the available evidence.
METHOD: The authors conducted a meta-analysis of diagnostic accuracy for QEEG in depressive illness, based on articles published between January 2000 and November 2017. The review included all articles that used QEEG to predict response during a major depressive episode, regardless of patient population, treatment, or QEEG marker. The primary meta-analytic outcome was the accuracy for predicting response to depression treatment, expressed as sensitivity, specificity, and the logarithm of the diagnostic odds ratio. Raters also judged each article on indicators of good research practice.
RESULTS: In 76 articles reporting 81 biomarkers, the meta-analytic estimates showed a sensitivity of 0.72 (95% CI=0.67-0.76) and a specificity of 0.68 (95% CI=0.63-0.73). The logarithm of the diagnostic odds ratio was 1.89 (95% CI=1.56-2.21), and the area under the receiver operator curve was 0.76 (95% CI=0.71-0.80). No specific QEEG biomarker or specific treatment showed greater predictive power than the all-studies estimate in a meta-regression. Funnel plot analysis suggested substantial publication bias. Most studies did not use ideal practices.
CONCLUSIONS: QEEG does not appear to be clinically reliable for predicting depression treatment response, as the literature is limited by underreporting of negative results, a lack of out-of-sample validation, and insufficient direct replication of previous findings. Until these limitations are remedied, QEEG is not recommended for guiding selection of psychiatric treatment.

Entities:  

Keywords:  Biological Markers; Mood Disorders-Unipolar; Neurophysiology

Mesh:

Substances:

Year:  2018        PMID: 30278789      PMCID: PMC6312739          DOI: 10.1176/appi.ajp.2018.17121358

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  110 in total

1.  Relation between frontal 3-7 Hz MEG activity and the efficacy of ECT in major depression.

Authors:  P Heikman; R Salmelin; J P Mäkelä; R Hari; H Katila; K Kuoppasalmi
Journal:  J ECT       Date:  2001-06       Impact factor: 3.635

2.  The performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessed.

Authors:  Jonathan J Deeks; Petra Macaskill; Les Irwig
Journal:  J Clin Epidemiol       Date:  2005-09       Impact factor: 6.437

3.  Meta-analysis of diagnostic and screening test accuracy evaluations: methodologic primer.

Authors:  Constantine Gatsonis; Prashni Paliwal
Journal:  AJR Am J Roentgenol       Date:  2006-08       Impact factor: 3.959

Review 4.  The value of quantitative electroencephalography in clinical psychiatry: a report by the Committee on Research of the American Neuropsychiatric Association.

Authors:  Kerry L Coburn; Edward C Lauterbach; Nash N Boutros; Kevin J Black; David B Arciniegas; C Edward Coffey
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2006       Impact factor: 2.198

5.  Anterior cingulate desynchronization and functional connectivity with the amygdala during a working memory task predict rapid antidepressant response to ketamine.

Authors:  Giacomo Salvadore; Brian R Cornwell; Fabio Sambataro; David Latov; Veronica Colon-Rosario; Frederick Carver; Tom Holroyd; Nancy DiazGranados; Rodrigo Machado-Vieira; Christian Grillon; Wayne C Drevets; Carlos A Zarate
Journal:  Neuropsychopharmacology       Date:  2010-03-10       Impact factor: 7.853

6.  An investigation of EEG, genetic and cognitive markers of treatment response to antidepressant medication in patients with major depressive disorder: a pilot study.

Authors:  D Spronk; M Arns; K J Barnett; N J Cooper; E Gordon
Journal:  J Affect Disord       Date:  2011-01       Impact factor: 4.839

7.  Resting-state EEG gamma power and theta-gamma coupling enhancement following high-frequency left dorsolateral prefrontal rTMS in patients with depression.

Authors:  Yoshihiro Noda; Reza Zomorrodi; Takashi Saeki; Tarek K Rajji; Daniel M Blumberger; Zafiris J Daskalakis; Motoaki Nakamura
Journal:  Clin Neurophysiol       Date:  2017-01-09       Impact factor: 3.708

Review 8.  Building better biomarkers: brain models in translational neuroimaging.

Authors:  Choong-Wan Woo; Luke J Chang; Martin A Lindquist; Tor D Wager
Journal:  Nat Neurosci       Date:  2017-02-23       Impact factor: 24.884

9.  Midline and right frontal brain function as a physiologic biomarker of remission in major depression.

Authors:  Ian A Cook; Aimee M Hunter; Michelle Abrams; Barbara Siegman; Andrew F Leuchter
Journal:  Psychiatry Res       Date:  2009-10-22       Impact factor: 3.222

10.  Neural Network Based Response Prediction of rTMS in Major Depressive Disorder Using QEEG Cordance.

Authors:  Turker Tekin Erguzel; Serhat Ozekes; Selahattin Gultekin; Nevzat Tarhan; Gokben Hizli Sayar; Ali Bayram
Journal:  Psychiatry Investig       Date:  2015-01-12       Impact factor: 2.505

View more
  33 in total

1.  Prospective testing of a neurophysiologic biomarker for treatment decisions in major depressive disorder: The PRISE-MD trial.

Authors:  Ian A Cook; Aimee M Hunter; Marissa M Caudill; Michelle J Abrams; Andrew F Leuchter
Journal:  J Psychiatr Res       Date:  2020-02-26       Impact factor: 4.791

2.  Use of machine learning in predicting clinical response to transcranial magnetic stimulation in comorbid posttraumatic stress disorder and major depression: A resting state electroencephalography study.

Authors:  Amin Zandvakili; Noah S Philip; Stephanie R Jones; Audrey R Tyrka; Benjamin D Greenberg; Linda L Carpenter
Journal:  J Affect Disord       Date:  2019-03-30       Impact factor: 4.839

3.  Frontal theta and posterior alpha in resting EEG: A critical examination of convergent and discriminant validity.

Authors:  Ezra E Smith; Craig E Tenke; Patricia J Deldin; Madhukar H Trivedi; Myrna M Weissman; Randy P Auerbach; Gerard E Bruder; Diego A Pizzagalli; Jürgen Kayser
Journal:  Psychophysiology       Date:  2019-10-02       Impact factor: 4.016

4.  Resting-State Quantitative Electroencephalography Demonstrates Differential Connectivity in Adolescents with Major Depressive Disorder.

Authors:  Molly McVoy; Michelle E Aebi; Kenneth Loparo; Sarah Lytle; Alla Morris; Nicole Woods; Elizabeth Deyling; Curtis Tatsuoka; Farhad Kaffashi; Samden Lhatoo; Martha Sajatovic
Journal:  J Child Adolesc Psychopharmacol       Date:  2019-05-09       Impact factor: 2.576

Review 5.  Device-Based Modulation of Neurocircuits as a Therapeutic for Psychiatric Disorders.

Authors:  Zhi-De Deng; Bruce Luber; Nicholas L Balderston; Melbaliz Velez Afanador; Michelle M Noh; Jeena Thomas; William C Altekruse; Shannon L Exley; Shriya Awasthi; Sarah H Lisanby
Journal:  Annu Rev Pharmacol Toxicol       Date:  2020-01-06       Impact factor: 13.820

Review 6.  Precision Psychiatry: Biomarker-Guided Tailored Therapy for Effective Treatment and Prevention in Major Depression.

Authors:  Candace Jones; Charles B Nemeroff
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

7.  Identification of Clinical Features and Biomarkers that may inform a Personalized Approach to rTMS for Depression.

Authors:  Sarah L Garnaat; Andrew M Fukuda; Shiwen Yuan; Linda L Carpenter
Journal:  Pers Med Psychiatry       Date:  2019-10-18

Review 8.  Isolated epileptiform activity in children and adolescents: prevalence, relevance, and implications for treatment.

Authors:  Ronald J Swatzyna; Martijn Arns; Jay D Tarnow; Robert P Turner; Emma Barr; Erin K MacInerney; Anne M Hoffman; Nash N Boutros
Journal:  Eur Child Adolesc Psychiatry       Date:  2020-07-14       Impact factor: 4.785

9.  Predicting treatment outcome in depression: an introduction into current concepts and challenges.

Authors:  Nicolas Rost; Elisabeth B Binder; Tanja M Brückl
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2022-05-19       Impact factor: 5.270

10.  Special Report on the Impact of the COVID-19 Pandemic on Clinical EEG and Research and Consensus Recommendations for the Safe Use of EEG.

Authors:  Salvatore Campanella; Kemal Arikan; Claudio Babiloni; Michela Balconi; Maurizio Bertollo; Viviana Betti; Luigi Bianchi; Martin Brunovsky; Carla Buttinelli; Silvia Comani; Giorgio Di Lorenzo; Daniel Dumalin; Carles Escera; Andreas Fallgatter; Derek Fisher; Giulia Maria Giordano; Bahar Guntekin; Claudio Imperatori; Ryouhei Ishii; Hendrik Kajosch; Michael Kiang; Eduardo López-Caneda; Pascal Missonnier; Armida Mucci; Sebastian Olbrich; Georges Otte; Andrea Perrottelli; Alessandra Pizzuti; Diego Pinal; Dean Salisbury; Yingying Tang; Paolo Tisei; Jijun Wang; Istvan Winkler; Jiajin Yuan; Oliver Pogarell
Journal:  Clin EEG Neurosci       Date:  2020-09-25       Impact factor: 1.843

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.